The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
Both XueZhiKang and Statins are cholesterol-lowering medications that are often prescribed
for individuals with high cholesterol and who are at risk for cardiovascular disease (CVD).
Several studies, including one randomized, double-blind, placebo-controlled clinical trial,
have suggested that the use of statins is more frequently associated with fatigue. And
XueZhiKang may be not. The purpose of this study is to compare the effect of these two
medications on fatigue in persons who are at moderate to low CVD risk based on the risk
estimation system in ESC(European Society of Cardiology)/ESA(European Atherosclerosis
Society) guidelines (2011) for the management of dyslipidemias.